Schmitz et al. [19] reported that MYD88 mutations frequently co-occur with CD79B mutations, forming the MCD (MYD88/CD79B) genetic subtype, observed in 71 out of 574 DLBCL cases. The gene discussed is CD79B; the disease is diffuse large B-cell lymphoma.